Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JNJ-26076713, an orally active alpha V integrin antagonist, represents a potential therapeutic candidate for the treatment of macular edema, age-related macular degeneration, and proliferative diabetic retinopathy.
説明 | JNJ-26076713, an orally active alpha V integrin antagonist, represents a potential therapeutic candidate for the treatment of macular edema, age-related macular degeneration, and proliferative diabetic retinopathy. |
別名 | JNJ26076713 |
分子量 | 490.64 |
分子式 | C29H38N4O3 |
CAS No. | 669076-03-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
JNJ-26076713 669076-03-3 JNJ 26076713 JNJ26076713 Inhibitor inhibitor inhibit